Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_2
2
50%
Ph phase_1
1
25%
Ph phase_3
1
25%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 2Efficacy & side effects
2(50.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (25.0%)
Phase 22 (50.0%)
Phase 31 (25.0%)

Trials by Status

not_yet_recruiting125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingphase_3

A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

NCT07136805
completedphase_2

Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery

NCT06164743
completedphase_1

Pharmacokinetics of VVN461 Ophthalmic Solution

NCT06906198
completedphase_2

A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

NCT06679153

Clinical Trials (4)

Showing 4 of 4 trials
NCT07136805Phase 3

A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

Not Yet Recruiting
NCT06164743Phase 2

Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery

Completed
NCT06906198Phase 1

Pharmacokinetics of VVN461 Ophthalmic Solution

Completed
NCT06679153Phase 2

A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4